These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 25181458
1. c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine. Chaudhary P, Vishwanatha JK. Biochem Pharmacol; 2014 Oct 15; 91(4):457-73. PubMed ID: 25181458 [Abstract] [Full Text] [Related]
2. Induction of apoptosis in human hepatoblastoma cells by tetrandrine via caspase-dependent Bid cleavage and cytochrome c release. Oh SH, Lee BH. Biochem Pharmacol; 2003 Sep 01; 66(5):725-31. PubMed ID: 12948852 [Abstract] [Full Text] [Related]
3. Tetrandrine-induced apoptosis is mediated by activation of caspases and PKC-delta in U937 cells. Jang BC, Lim KJ, Paik JH, Cho JW, Baek WK, Suh MH, Park JB, Kwon TK, Park JW, Kim SP, Shin DH, Song DK, Bae JH, Mun KC, Suh SI. Biochem Pharmacol; 2004 May 15; 67(10):1819-29. PubMed ID: 15130759 [Abstract] [Full Text] [Related]
4. p38alpha, but not p38beta, inhibits the phosphorylation and presence of c-FLIPS in DISC to potentiate Fas-mediated caspase-8 activation and type I apoptotic signaling. Tourian L, Zhao H, Srikant CB. J Cell Sci; 2004 Dec 15; 117(Pt 26):6459-71. PubMed ID: 15572410 [Abstract] [Full Text] [Related]
5. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. Singh SV, Srivastava SK, Choi S, Lew KL, Antosiewicz J, Xiao D, Zeng Y, Watkins SC, Johnson CS, Trump DL, Lee YJ, Xiao H, Herman-Antosiewicz A. J Biol Chem; 2005 May 20; 280(20):19911-24. PubMed ID: 15764812 [Abstract] [Full Text] [Related]
6. Mixed lineage kinase 3 connects reactive oxygen species to c-Jun NH2-terminal kinase-induced mitochondrial apoptosis in genipin-treated PC3 human prostate cancer cells. Hong HY, Kim BC. Biochem Biophys Res Commun; 2007 Oct 19; 362(2):307-12. PubMed ID: 17707342 [Abstract] [Full Text] [Related]
7. Phosphorylation of Fas-associated death domain contributes to enhancement of etoposide-induced apoptosis in prostate cancer cells. Shimada K, Nakamura M, Ishida E, Kishi M, Yonehara S, Konishi N. Jpn J Cancer Res; 2002 Oct 19; 93(10):1164-74. PubMed ID: 12417047 [Abstract] [Full Text] [Related]
8. Autophagy modulators sensitize prostate epithelial cancer cell lines to TNF-alpha-dependent apoptosis. Giampietri C, Petrungaro S, Padula F, D'Alessio A, Marini ES, Facchiano A, Filippini A, Ziparo E. Apoptosis; 2012 Nov 19; 17(11):1210-22. PubMed ID: 22923157 [Abstract] [Full Text] [Related]
9. Tetrandrine induces mitochondria-mediated apoptosis in human gastric cancer BGC-823 cells. Qin R, Shen H, Cao Y, Fang Y, Li H, Chen Q, Xu W. PLoS One; 2013 Nov 19; 8(10):e76486. PubMed ID: 24098511 [Abstract] [Full Text] [Related]
10. The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanism. Pei XY, Dai Y, Grant S. Mol Cancer Ther; 2004 Dec 19; 3(12):1513-24. PubMed ID: 15634644 [Abstract] [Full Text] [Related]
11. c-Jun NH2-terminal kinase-dependent Fas activation contributes to etoposide-induced apoptosis in p53-mutated prostate cancer cells. Shimada K, Nakamura M, Ishida E, Kishi M, Yonehara S, Konishi N. Prostate; 2003 Jun 01; 55(4):265-80. PubMed ID: 12712406 [Abstract] [Full Text] [Related]
12. ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells. Le Clorennec C, Lazrek Y, Dubreuil O, Sampaio C, Larbouret C, Lanotte R, Poul MA, Barret JM, Prost JF, Pèlegrin A, Chardès T. Cell Commun Signal; 2019 Aug 23; 17(1):106. PubMed ID: 31443721 [Abstract] [Full Text] [Related]
13. Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents. Sánchez-Pérez T, Ortiz-Ferrón G, López-Rivas A. Cell Death Differ; 2010 May 23; 17(5):883-94. PubMed ID: 19942932 [Abstract] [Full Text] [Related]
14. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells. Jia L, Yu W, Wang P, Li J, Sanders BG, Kline K. Prostate; 2008 Mar 01; 68(4):427-41. PubMed ID: 18196534 [Abstract] [Full Text] [Related]
15. Tetrandrine regulates hepatic stellate cell activation via TAK1 and NF-κB signaling. Li X, Jin Q, Wu YL, Sun P, Jiang S, Zhang Y, Zhang DQ, Zhang YJ, Lian LH, Nan JX. Int Immunopharmacol; 2016 Jul 01; 36():263-270. PubMed ID: 27179306 [Abstract] [Full Text] [Related]
16. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, Trump DL, Lee YJ, Singh SV. Oncogene; 2004 Jul 22; 23(33):5594-606. PubMed ID: 15184882 [Abstract] [Full Text] [Related]
17. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment]. Zhang YX, Kong CZ. Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):271-5. PubMed ID: 18361842 [Abstract] [Full Text] [Related]
18. Radiation and anticancer drugs can facilitate mitochondrial bypass by CD95/Fas via c-FLIP downregulation. Verbrugge I, Maas C, Heijkoop M, Verheij M, Borst J. Cell Death Differ; 2010 Mar 22; 17(3):551-61. PubMed ID: 19798106 [Abstract] [Full Text] [Related]
19. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase. Singh SV, Choi S, Zeng Y, Hahm ER, Xiao D. Cancer Res; 2007 Aug 01; 67(15):7439-49. PubMed ID: 17671214 [Abstract] [Full Text] [Related]
20. Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. Liu C, Gong K, Mao X, Li W. Int J Cancer; 2011 Sep 15; 129(6):1519-31. PubMed ID: 21128229 [Abstract] [Full Text] [Related] Page: [Next] [New Search]